Short-Course RT Plus Chemo Can Decrease Distant Metastasis in High-Risk LARC
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
The use of total neoadjuvant therapy for locally advanced rectal cancer has increased significantly in recent years, a study suggests.
A nonsurgical treatment strategy employing chemoradiotherapy is feasible for patients with early rectal cancer, a phase 3 trial suggests.
Changes in treatment have led to improvements in overall survival for US patients with rectal cancer, a study suggests.
Researchers have developed a dynamic clinical calculator that estimates conditional recurrence-free survival after total neoadjuvant therapy in patients with rectal cancer.
Robotic surgery resulted in improved quality of resection, faster postoperative recovery, fewer postoperative and intraoperative complications, shorter hospital stays, and decreased surgical trauma.
Adding galunisertib to neoadjuvant chemoradiotherapy may improve responses in patients with locally advanced rectal cancer.
Patients treated with radiotherapy had a greater risk of second primary cancer when compared with patients who underwent surgery or surveillance.
Overall, adjuvant chemotherapy does not appear to increase the risk of second cancers for patients with stage III-IV colon cancer.
Researchers developed a strategy for providing rectal cancer survivors with dietary guidance and posttreatment care.